Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
PULM
Home
/
PULM

NASDAQ
$1.52
$1.52

Overview

Price performance
Low
$1.09
High
$1.52
Market closed. Last updated: Nov 4, 2026, 9:00 PM UTC
$
1.52
0.19 (14.29%)
Average, 50 days
$1.48
$1.70
Open
$1.09
Previous close
$1.33
52-week high
$4.98
Nov 17, 2025 (1 year ago)
52-week low
$1.06
Nov 4, 2026 (2 days ago)
43.40%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
5.55M
Volume
218 269
Total Return (3M)
-8.43%
Total Return (1Y)
-68.13%
2.62
Sector
Healthcare
Links
Tags
Healthcare
Biotechnology
NASDAQ
US
Website
pulmatrix.com
About
Pulmatrix, Inc. (PULM) is a clinical-stage biotechnology firm focused on creating and advancing inhaled treatments. The company's primary goal is to address significant unmet medical needs in respiratory and other diseases within the United States. Central to their approach is the innovative iSPERSE (inhaled small particles easily respirable and emitted) technology. This proprietary platform allows for the precise delivery of both small and large molecule therapeutics directly into the lungs, achieving either localized effects or systemic distribution throughout the body. Pulmatrix's development pipeline includes several key candidates: Pulmazole: An inhaled antifungal drug being developed to treat allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis. PUR1800: A narrow spectrum kinase inhibitor currently undergoing Phase 1b clinical trials for individuals suffering from stable moderate-to-severe chronic obstructive pulmonary disease (COPD). PUR3100: An iSPERSE-formulated version of dihydroergotamine, intended for the rapid relief of acute migraine attacks. The company also maintains strategic collaborations, including a licensing arrangement with RespiVert Ltd. for access to a range of kinase inhibitor drug candidates, a partnership with Cipla Technologies LLC for the development and commercialization of Pulmazole, and a collaboration and license agreement with Sensory Cloud, Inc. Established in 2003, Pulmatrix, Inc. is headquartered in Lexington, Massachusetts.

Frequently asked questions

PULM · Pulmatrix, Inc.

01What is Pulmatrix, Inc. stock price today?

The current price of PULM is $1.52 — it has increased by 14.29% since the previous close. Data as of Nov 4, 2026.

02Is Pulmatrix, Inc. stock price growing?

PULM is up 7.80% over the past week, down 3.18% over the past month and down 68.13% over the past year. The price is below its 200-day moving average of $1.70.

03What is Pulmatrix, Inc. market cap?

Pulmatrix, Inc. has a market capitalization of $5.55M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

04How volatile is PULM stock?

In the latest trading session PULM moved between $1.09 and $1.53, a range of 28.62% of its current price.

05What are PULM stock 52-week high and low?

Over the past 52 weeks PULM has traded between $1.06 and $4.98. The current price is 69.48% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.